Genetic analysis of G12P[8] rotaviruses detected in the largest U.S. G12 genotype outbreak on record

Infection, Genetics and Evolution

Volumn 21, Issue , 2014, Pages 214-219

  Mijatovic Rustempasic, Slavica ^a   Teel, Elizabeth N ^a   Kerin, Tara K ^a   Hull, Jennifer J ^a   Roy, Sunando ^a   Weinberg, Geoffrey A ^b   Payne, Daniel C ^a   Parashar, Umesh D ^a   Gentsch, Jon R ^a   Bowen, Michael D ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Rotavirus; USA; Vaccine; VP4 protein; VP7 protein

Indexed keywords

AMINO ACID; PROTEIN VP4; PROTEIN VP7; CAPSID PROTEIN; ROTAVIRUS VACCINE; VIRUS ANTIGEN; VP4 PROTEIN, ROTAVIRUS; VP7 PROTEIN, ROTAVIRUS;

ARTICLE; EPIDEMIC; GENE CLUSTER; GENETIC ANALYSIS; GENOTYPE; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; ROTAVIRUS; SEQUENCE ANALYSIS; UNITED STATES; VIRAL GENETICS; VP4 GENE; VP7 GENE; CHEMISTRY; CLASSIFICATION; EPIDEMIOLOGY; GASTROENTERITIS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MOLECULAR EVOLUTION; PHYLOGENY; ROTAVIRUS INFECTIONS; VIROLOGY; VIRUS GENOME;

ROTAVIRUS;

ANTIGENS, VIRAL; CAPSID PROTEINS; DISEASE OUTBREAKS; EVOLUTION, MOLECULAR; GASTROENTERITIS; GENETIC VARIATION; GENOME, VIRAL; GENOTYPE; HUMANS; PHYLOGENY; POLYMORPHISM, GENETIC; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; UNITED STATES;

EID: 84890027457     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2013.11.004     Document Type: Article

References (47)

1. Anisimova M., Gascuel O. Approximate likelihood-ratio test for branches: a fast, accurate, and powerful alternative. Syst. Biol. 2006, 55:539-552.
2. Anonymous Meeting of the Strategic Advisory Group of Experts on Immunization, October 2009 - conclusions and recommendations. Wkly Epidemiol. Rec. 2009, 84:517-532.
3. Arias C.F., Romero P., Alvarez V., Lopez S. Trypsin activation pathway of rotavirus infectivity. J. Virol. 1996, 70:5832-5839.
4. Banyai K., Bogdan A., Kisfali P., Molnar P., Mihaly I., Melegh B., Martella V., Gentsch J.R., Szucs G. Emergence of serotype G12 rotaviruses, Hungary. Emerg. Infect. Dis. 2007, 13:916-919.
5. *). J. Mol. Biol. 2007, 367:1215-1226.
6. Das S., Varghese V., Chaudhury S., Barman P., Mahapatra S., Kojima K., Bhattacharya S.K., Krishnan T., Ratho R.K., Chhotray G.P., Phukan A.C., Kobayashi N., Naik T.N. Emergence of novel human group A rotavirus G12 strains in India. J. Clin. Microbiol. 2003, 41:2760-2762.
7. Delport W., Poon A.F.Y., Frost S.D.W., Kosakovsky Pond S.L. Datamonkey 2010: a suite of phylogenetic analysis tools for evolutionary biology. Bioinformatics (Oxford, England) 2010, 26:2455-2457.
8. Desselberger U., Huppertz H.I. Immune responses to rotavirus infection and vaccination and associated correlates of protection. J. Infect. Dis. 2011, 203:188-195.
9. Donker N.C., Kirkwood C.D. Selection and evolutionary analysis in the nonstructural protein NSP2 of rotavirus A. Infect. Genet. Evol. 2012, 12:1355-1361.
10. Dormitzer P.R., Sun Z.Y., Wagner G., Harrison S.C. The rhesus rotavirus VP4 sialic acid binding domain has a galectin fold with a novel carbohydrate binding site. EMBO J. 2002, 21:885-897.
11. Estes M.K. Rotaviruses and their replication. Fields Virology 1996, 1625-1655. Lippincott-Raven, Philadelphia PA. third ed. B.N. Fields, D.M. Knipe, P.M. Howley, R.M. Chanock, J.L. Melnick, T.P. Monath, B. Roizman, S.E. Straus (Eds.).
12. Estes M.K., Kapikian A.Z. Rotaviruses. Fields Virology 2007, 1917-1974. Lippincott Williams & Wilkins. fifth ed. D.M. Knipe, P.M. Howley, D.E. Griffin, R.A. Lamb, M.A. Martin, B. Roizman, S.E. Straus (Eds.).
13. Freeman M.M., Kerin T., Hull J., Teel E., Esona M., Parashar U., Glass R.I., Gentsch J.R. Phylogenetic analysis of novel G12 rotaviruses in the United States: a molecular search for the origin of a new strain. J. Med. Virol. 2009, 81:736-746.
14. Gentsch J.R., Glass R.I., Woods P., Gouvea V., Gorziglia M., Flores J., Das B.K., Bhan M.K. Identification of group A rotavirus gene 4 types by polymerase chain reaction. J. Clin. Microbiol. 1992, 30:1365-1373.
15. Gilbert J.M., Greenberg H.B. Cleavage of rhesus rotavirus VP4 after arginine 247 is essential for rotavirus-like particle-induced fusion from without. J. Virol. 1998, 72:5323-5327.
16. Gorziglia M., Hoshino Y., Buckler-White A., Blumentals I., Glass R., Flores J., Kapikian A.Z., Chanock R.M. Conservation of amino acid sequence of VP8 and cleavage region of 84-kDa outer capsid protein among rotaviruses recovered from asymptomatic neonatal infection. Proc. Natl. Acad. Sci. USA 1986, 83:7039-7043.
17. Gorziglia M., Larralde G., Ward R.L. Neutralization epitopes on rotavirus SA11 4fM outer capsid proteins. J. Virol. 1990, 64:4534-4539.
18. Gouy M., Guindon S., Gascuel O., Guindon S., Gascuel O. SeaView version 4: a multiplatform graphical user interface for sequence alignment and phylogenetic tree building. Mol. Biol. Evol. 2010, 27:221-224.
19. Griffin D.D., Nakagomi T., Hoshino Y., Nakagomi O., Kirkwood C.D., Parashar U.D., Glass R.I., Gentsch J.R. Characterization of nontypeable rotavirus strains from the United States: identification of a new rotavirus reassortant (P2A[6], G12) and rare P3[9] strains related to bovine rotaviruses. Virology 2002, 294:256-269.
20. Guindon S., Gascuel O. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst. Biol. 2003, 52:696-704.
21. Hull J.J., Teel E.N., Kerin T.K., Freeman M.M., Esona M.D., Gentsch J.R., Cortese M.M., Parashar U.D., Glass R.I., Bowen M.D. United States rotavirus strain surveillance from 2005 to 2008: genotype prevalence before and after vaccine introduction. Pediatr. Infect. Dis. J. 2011, 30:S42-47.
22. Iturriza-Gomara M., Dallman T., Banyai K., Bottiger B., Buesa J., Diedrich S., Fiore L., Johansen K., Koopmans M., Korsun N., Koukou D., Kroneman A., Laszlo B., Lappalainen M., Maunula L., Marques A.M., Matthijnssens J., Midgley S., Mladenova Z., Nawaz S., Poljsak-Prijatelj M., Pothier P., Ruggeri F.M., Sanchez-Fauquier A., Steyer A., Sidaraviciute-Ivaskeviciene I., Syriopoulou V., Tran A.N., Usonis V., M V.A.N.R., A D.E.R., Gray J. Rotavirus genotypes co-circulating in Europe between 2006 and 2009 as determined by EuroRotaNet, a pan-European collaborative strain surveillance network. Epidemiol. Infect. 2011, 139:895-909.
23. Kirkwood C.D., Bishop R.F., Coulson B.S. Human rotavirus VP4 contains strain-specific, serotype-specific and cross-reactive neutralization sites. Arch. Virol. 1996, 141:587-600.
24. Kirkwood C.D., Boniface K., Bogdanovic-Sakran N., Masendycz P., Barnes G.L., Bishop R.F. Rotavirus strain surveillance - an Australian perspective of strains causing disease in hospitalised children from 1997 to 2007. Vaccine 2009, 27(Suppl. 5):F102-107.
25. Lopez S., Arias C.F., Bell J.R., Strauss J.H., Espejo R.T. Primary structure of the cleavage site associated with trypsin enhancement of rotavirus SA11 infectivity. Virology 1985, 144:11-19.
26. Lopez S., Arias C.F., Mendez E., Espejo R.T. Conservation in rotaviruses of the protein region containing the two sites associated with trypsin enhancement of infectivity. Virology 1986, 154:224-227.
27. Matthijnssens J., Heylen E., Zeller M., Rahman M., Lemey P., Van Ranst M. Phylodynamic analyses of rotavirus genotypes G9 and G12 underscore their potential for swift global spread. Mol. Biol. Evol. 2010, 27:2431-2436.
28. Matthijnssens J., Ciarlet M., McDonald S.M., Attoui H., Banyai K., Brister J.R., Buesa J., Esona M.D., Estes M.K., Gentsch J.R., Iturriza-Gomara M., Johne R., Kirkwood C.D., Martella V., Mertens P.P., Nakagomi O., Parreno V., Rahman M., Ruggeri F.M., Saif L.J., Santos N., Steyer A., Taniguchi K., Patton J.T., Desselberger U., Van Ranst M. Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG). Arch. Virol. 2011, 156:1397-1413.
29. Maunula L., von Bonsdorff C.H. Short sequences define genetic lineages: phylogenetic analysis of group A rotaviruses based on partial sequences of genome segments 4 and 9. J. Gen. Virol. 1998, 79(Pt 2):321-332.
30. Parashar U.D., Burton A., Lanata C., Boschi-Pinto C., Shibuya K., Steele D., Birmingham M., Glass R.I. Global mortality associated with rotavirus disease among children in 2004. J. Infect. Dis. 2009, 200(Suppl. 1):S9-S15.
31. Patel M.M., Steele D., Gentsch J.R., Wecker J., Glass R.I., Parashar U.D. Real-world impact of rotavirus vaccination. Pediatr. Infect. Dis. J. 2011, 30:S1-5.
32. Payne D.C., Staat M.A., Edwards K.M., Szilagyi P.G., Gentsch J.R., Stockman L.J., Curns A.T., Griffin M., Weinberg G.A., Hall C.B., Fairbrother G., Alexander J., Parashar U.D. Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States. Pediatrics 2008, 122:1235-1243.
33. Payne D.C., Szilagyi P.G., Staat M.A., Edwards K.M., Gentsch J.R., Weinberg G.A., Hall C.B., Curns A.T., Clayton H., Griffin M.R., Fairbrother G., Parashar U.D. Secular variation in United States rotavirus disease rates and serotypes: implications for assessing the rotavirus vaccination program. Pediatr. Infect. Dis. J. 2009, 28:948-953.
34. Payne D.C., Boom J.A., Staat M.A., Edwards K.M., Szilagyi P.G., Klein E.J., Selvarangan R., Azimi P.H., Harrison C., Moffatt M., Johnston S.H., Sahni L.C., Baker C.J., Rench M.A., Donauer S., McNeal M., Chappell J., Weinberg G.A., Tasslimi A., Tate J.E., Wikswo M., Curns A.T., Sulemana I., Mijatovic-Rustempasic S., Esona M.D., Bowen M.D., Gentsch J.R., Parashar U.D. Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years old, 2009-2011. Clin. Infect. Dis 2013, 10.1093/cid/cit164.
35. Pietsch C., Liebert U.G. Human infection with G12 rotaviruses, Germany. Emerg. Infect. Dis. 2009, 15:1512-1515.
36. Pond S.L.K., Frost S.D.W. Datamonkey: rapid detection of selective pressure on individual sites of codon alignments. Bioinformatics (Oxford, England) 2005, 21:2531-2533.
37. Pongsuwanna Y., Guntapong R., Chiwakul M., Tacharoenmuang R., Onvimala N., Wakuda M., Kobayashi N., Taniguchi K. Detection of a human rotavirus with G12 and P[9] specificity in Thailand. J. Clin. Microbiol. 2002, 40:1390-1394.
38. Rahman M., Matthijnssens J., Yang X., Delbeke T., Arijs I., Taniguchi K., Iturriza-Gomara M., Iftekharuddin N., Azim T., Van Ranst M. Evolutionary history and global spread of the emerging g12 human rotaviruses. J. Virol. 2007, 81:2382-2390.
39. Ruiz-Palacios G.M., Perez-Schael I., Velazquez F.R., Abate H., Breuer T., Clemens S.C., Cheuvart B., Espinoza F., Gillard P., Innis B.L., Cervantes Y., Linhares A.C., Lopez P., Macias-Parra M., Ortega-Barria E., Richardson V., Rivera-Medina D.M., Rivera L., Salinas B., Pavia-Ruz N., Salmeron J., Ruttimann R., Tinoco J.C., Rubio P., Nunez E., Guerrero M.L., Yarzabal J.P., Damaso S., Tornieporth N., Saez-Llorens X., Vergara R.F., Vesikari T., Bouckenooghe A., Clemens R., De Vos B., O'Ryan M. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N. Engl. J. Med. 2006, 354:11-22.
40. Samajdar S., Varghese V., Barman P., Ghosh S., Mitra U., Dutta P., Bhattacharya S.K., Narasimham M.V., Panda P., Krishnan T., Kobayashi N., Naik T.N. Changing pattern of human group A rotaviruses: emergence of G12 as an important pathogen among children in eastern India. J. Clin. Virol. 2006, 36:183-188.
41. Song X.-f., Hao Y. Adaptive evolution of rotavirus VP7 and NSP4 genes in different species. Comp. Biol. Chem. 2009, 33:344-349.
42. Soskine M., Tawfik D.S. Mutational effects and the evolution of new protein functions. Nat. Rev. Genet. 2010, 11:572-582.
43. Taniguchi K., Urasawa T., Kobayashi N., Gorziglia M., Urasawa S. Nucleotide sequence of VP4 and VP7 genes of human rotaviruses with subgroup I specificity and long RNA pattern: implication for new G serotype specificity. J. Virol. 1990, 64:5640-5644.
44. Trojnar E., Sachsenröder J., Twardziok S., Reetz J., Otto P., Johne R. Identification of an avian group A rotavirus containing a novel VP4 gene with a close relationship to those of mammalian rotaviruses. J. Gen. Virol. 2013, 94:136-142.
45. Uchida R., Pandey B.D., Sherchand J.B., Ahmed K., Yokoo M., Nakagomi T., Cuevas L.E., Cunliffe N.A., Hart C.A., Nakagomi O. Molecular epidemiology of rotavirus diarrhea among children and adults in Nepal: detection of G12 strains with P[6] or P[8] and a G11P[25] strain. J. Clin. Microbiol. 2006, 44:3499-3505.
46. Vesikari T., Matson D.O., Dennehy P., Van Damme P., Santosham M., Rodriguez Z., Dallas M.J., Heyse J.F., Goveia M.G., Black S.B., Shinefield H.R., Christie C.D., Ylitalo S., Itzler R.F., Coia M.L., Onorato M.T., Adeyi B.A., Marshall G.S., Gothefors L., Campens D., Karvonen A., Watt J.P., O'Brien K.L., DiNubile M.J., Clark H.F., Boslego J.W., Offit P.A., Heaton P.M. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N. Engl. J. Med. 2006, 354:23-33.
47. Zeller M., Patton J.T., Heylen E., De Coster S., Ciarlet M., Van Ranst M., Matthijnssens J. Genetic analyses reveal differences in the VP7 and VP4 antigenic epitopes between human rotaviruses circulating in Belgium and rotaviruses in Rotarix and RotaTeq. J. Clin. Microbiol. 2012, 50:966-976. Epub 2011 Dec 2021.